Liqui-Vict 2XTM — veterinary medication

Overview

Source: Animal Drugs @ FDA

Proprietary name

Liqui-Vict 2XTM

Active ingredient

Pyrantel Pamoate

Application type

ANADA

Sponsor

Happy Jack, Inc.

Applications on record

1

First published

December 19, 2017

Adverse event reports

Source: openFDA VeDDRA

5,146

Reports mentioning this ingredient

August 10, 1987 – March 17, 2026

1,027

Classified serious

per reporter assessment

814

Lack of expected efficacy

resistance signal

228

Human operator exposure

needle-stick or splash

Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “PYRANTEL PAMOATE”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term)	Reports	Relative frequency
Vomiting	952
Diarrhoea	512
Death	475
Depression	416
Anorexia	383
Lethargy (see also Central nervous system depression in 'Neurological')	273
No sign	263
Accidental exposure	224
Lack of efficacy (endoparasite) - hookworm	131
Bloody diarrhoea	111
INEFFECTIVE, ASCARIDS NOS	110
Ataxia	110
Convulsion	97
INEFFECTIVE, WORMS NOS	94
Unclassifiable adverse event	91
Cough	79
Vocalisation	75
Fever	70
Hypersalivation	69
Abdominal pain	67

Species affected

Source: openFDA VeDDRA

Dog 4,303 Cat 370 Horse 138 Human 88 Other 23 Sheep 1 Chicken 1 Goat 1 Pig 1

Regulatory context

Abbreviated New Animal Drug Application (ANADA). A generic animal drug demonstrating bioequivalence, pharmaceutical equivalence and identical manufacturing criteria to the pioneer application. Veterinary generics have no formal therapeutic-equivalence coding system; they match the pioneer NADA specification instead.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA	FDA CVM	Applications, sponsor, status, withdrawal
Animal & Veterinary Events	FDA CVM	VeDDRA adverse event aggregates by active ingredient